Beschreibung:
This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.
1. New Biology and the Foundations of a Health Bioeconomy2. Crisis in the Pharmaceutical Industry and the Promise of New Biology3. The 'Broken Middle' of Health Innovation 4. Organizational Transformations and the Value of Interdisciplinarity5. Regulation, Policy and Governance of Advanced Therapies6. The Role of Patients and Publics in Health Innovation7. Rethinking Value and Expectations in the Health Bioeconomy